ONCOGENE TRANSFORMATION FREQUENCY OF NONSENESCENT SFME CELLS IS INCREASED BY C-MYC

被引:0
|
作者
RAWSON, C [1 ]
SHIRAHATA, S [1 ]
COLLODI, P [1 ]
NATSUNO, T [1 ]
BARNES, D [1 ]
机构
[1] OREGON STATE UNIV,ENVIRONM HLTH SCI CTR,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immortalized, postcrisis mouse embryo cell cultures derived in serum-containing medium display genomic abnormalities and an altered, preneoplastic phenotype. These lines can be transformed with single oncogenes, such as Ha-ras, while efficient transformation of precrisis, genomically unaltered rodent embryo cultures require cooperating oncogenes, such as Ha-ras and the mouse c-myc gene constitutively expressed. Serum-free mouse embryo (SFME) cells, cultured under conditions in which serum is replaced by growth factors and other supplements, are 'immortalized' in the genomically unaltered state. SFME cells do not exhibit growth crisis or gross chromosomal aberration, and are dependent on epidermal growth factor for survival, growth inhibited by serum, and are nontumorigenic. Transformation of SFME cells can be achieved with ras alone, but the introduction of c-myc increased the transfection frequency upon subsequent transfection with ras by as much as twenty fold. Similar results were obtained with mutationally activated neu oncogene and with genomic human tumor DNA. Constitutive expression of c-myc alone did not alter the properties of the SFME cells. These results demonstrate that c-myc alters cellular responses to oncogenes in a culture system in which oncogene-induced immortalization is not a factor, indicating that the effects of myc may extend beyond an 'immortalization' function in these cells.
引用
收藏
页码:487 / 489
页数:3
相关论文
共 50 条
  • [1] Oncogene addiction to c-MYC in myeloma cells
    Holien, Toril
    Sundan, Anders
    ONCOTARGET, 2012, 3 (08) : 739 - 740
  • [2] CHANGE IN THE EXPRESSION OF THE C-MYC ONCOGENE DURING CELL-TRANSFORMATION
    SHALL, S
    TAVASSOLI, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (11): : 1416 - 1416
  • [3] INCREASED EXPRESSION, DEREGULATION AND AMPLIFICATION OF THE ONCOGENE C-MYC IN HT-29 CELLS (HUMAN)
    FORGUELAFITTE, ME
    DIABETES & METABOLISM, 1987, 13 (02): : 166 - 166
  • [4] IMMORTALIZATION OF MOUSE NEURAL PRECURSOR CELLS BY THE C-MYC ONCOGENE
    BARTLETT, PF
    REID, HH
    BAILEY, KA
    BERNARD, O
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) : 3255 - 3259
  • [5] THE C-MYC ONCOGENE IN TUMOR PROGRESSION
    GARTE, SJ
    CRITICAL REVIEWS IN ONCOGENESIS, 1993, 4 (04): : 435 - 449
  • [6] 25 years of the c-Myc oncogene
    Cole, Michael D.
    Henriksson, Marie
    SEMINARS IN CANCER BIOLOGY, 2006, 16 (04) : 241 - 241
  • [7] PRIVILEGED PARTNERS OF THE C-MYC ONCOGENE
    LACAZEMASMONTEIL, T
    M S-MEDECINE SCIENCES, 1991, 7 (08): : 865 - 866
  • [8] POSTTRANSCRIPTIONAL REGULATION OF C-MYC ONCOGENE IN NORMAL AND TUMOR-CELLS
    PIECHACZYK, M
    BLANCHARD, JM
    DANI, C
    BONNIEU, A
    MECHTI, N
    LEBLEU, B
    JEANTEUR, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 138 - 138
  • [9] Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer
    Zakiryanova, Gulnur K.
    Kustova, Elena
    Urazalieva, Nataliya T.
    Baimuchametov, Emile T.
    Nakisbekov, Narymzhan N.
    Shurin, Michael R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03):
  • [10] EFFECTS OF RECOMBINANT INTERFERON ON THE C-MYC ONCOGENE PRODUCT IN DAUDI CELLS
    GERADTS, J
    SIKORA, K
    BRITISH JOURNAL OF CANCER, 1986, 53 (03) : 424 - 424